Zydus Lifesciences Ltd on Friday said it has signed an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

Zydus Lifesciences has partnered with US-based Myriad Genetics to bring advanced cancer risk and prognostic tests to India, aiming to boost personalized oncology care.

The Vehlive OBD2 Scanner Diagnostic Tool is on sale for $21, which is $22 off the original $43 price tag. This item boasts ...

While Windows 11 offers a host of great functionality, there are settings that work better when changed. Here are some of ...

Virohan, an India-based provider of industry-aligned healthcare education, has raised ₹65 crore (about $7.5 million) as part of its ongoing Series B round ...

Market experts have previously highlighted Healwell AI as a compelling, focused bet on artificial intelligence within medical diagnostics. The current realit ...

Interroll Holding AG ( VTX:INRN ), might not be a large cap stock, but it saw significant share price movement ...

The 5 testing & diagnostics services stocks we track reported a very strong Q3. As a group, revenues beat analysts’ consensus ...

Tempus AI has EV/forward revenue under 10x, positive EBITDA, 33% genomics growth, and $150M in new contracts. Find out why ...

BioMarin Pharmaceutical Inc. and Amicus Therapeutics announced today that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an all-cash transaction for a total ...

On December 15, 2025, Zoetis announced a proposed private offering of $1.75 billion in convertible senior notes due 2029, with an option for initial purchasers to buy an additional $250 million, ...